DOYLE THOMAS JAMES (SVP, Finance & Accounting) received a stock award from KURA ONCOLOGY, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/6/2026ACC: 0001193125-26-004569
Officer· SVP, Finance & Accounting
Since Feb 2022
+63.75K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
63.75K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+21.25K
Price / share
—
Trade value
—
% of position
16.2%
1/2/2026
131.06K→152.31K
Total
Net shares
+21.25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | A · Award | +21.25K | — | — | 16.2% | 131.06K | 152.31K |
| Total | +21.25K | $0.00 | ||||||
Derivative Transactions1
Option to purchase common stock
Direct
Converts to
Common Stock
42.50K shares
Shares
+42.50K
Strike price
10.335
Held after
42.50K
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to purchase common stock Direct | Common Stock42.50K shares | 1/2/2026 | A · Award | +42.50K | 10.335 | — | 42.50K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned500.00
Total
500.00 indirect500.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 500.00 | Indirect |
| Total | 500.00 | 500.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported